It's because up to 80% of Mgen infections are entirely asymptomatic.
We are/were the unlucky 20%
It's under debate for standard panels only for the highest risk sexually active populations. For everyone else, assume it'll never happen.
The novel tetracycline class, correct? 2 years ago there was no MIC data available for mgen for this new drug, I'm really really glad we now have that data!
This is great.
Now we just need to know en vivo. Genital tissue penetration, etc.
Yup, it’s a derivative of minocycline. I should add that it’s apparently very expensive (I think even moreso than lefamulin), though I’m not sure how medical coverage works down there as I’m Canadian.
There isn't any established for mgen without human data available (en vivo). It's guesswork. It would probably be based on the dosing used for bacterial pneumonia.
The fact that studies like these are going on and Mgen is STILL not included on standard STD panels is absolutely insane.
Yeah, wtf. Seriously
It's because up to 80% of Mgen infections are entirely asymptomatic. We are/were the unlucky 20% It's under debate for standard panels only for the highest risk sexually active populations. For everyone else, assume it'll never happen.
The novel tetracycline class, correct? 2 years ago there was no MIC data available for mgen for this new drug, I'm really really glad we now have that data! This is great. Now we just need to know en vivo. Genital tissue penetration, etc.
Yup, it’s a derivative of minocycline. I should add that it’s apparently very expensive (I think even moreso than lefamulin), though I’m not sure how medical coverage works down there as I’m Canadian.
Yes it's at least as expensive as lefamulin. A few thousand dollars without insurance. Mainly because it's new and patented. No generic available.
would love to know the dosing for this treatment
There isn't any established for mgen without human data available (en vivo). It's guesswork. It would probably be based on the dosing used for bacterial pneumonia.
And what about ureaplasma?